Vancouver, British Columbia – TheNewswire - June 15, 2022. Lexston Life Sciences Corp. (the “Company”) (CSE:LEXT) (OTC:LEXTF) announces the resignation of Dr. Philippe Henry from his positions as a director and the Chief Science Officer of the Company effective June 15, 2022.  The Company thanks Dr. Henry for his service.

On Behalf of the Board of Directors

LEXSTON LIFE SCIENCES CORP.

Jagdip Bal Chief Executive Officer

Telephone: (604) 928-8913

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.